PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'IHRC Inc, contracting agency to the Division of Viral Diseases, Atlanta, Georgia, USA.\', \'Seattle Children\'s Hospital, Seattle, Washington, USA.\', \'Department of Pediatrics, University of Cincinnati, Division of Infectious Diseases, Cincinnati Children\'s Hospital Medical Center, Cincinnati, Ohio, USA.\', \'University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.\', \'University of Missouri-Kansas City School of Medicine, Children\'s Mercy, Kansas City, Missouri, USA.\', \'Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'UPMC Children\'s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.\', \'Texas Children\'s Hospital, Houston, Texas, USA.\', \'Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.\', \'Department of Pediatrics, UCLA Mattel Children\'s Hospital, University of California at Los Angeles, Los Angeles, California, USA.\', \'Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/jpids/piaa075
?:hasPublicationType
?:journal
  • Journal of the Pediatric Infectious Diseases Society
is ?:pmid of
?:pmid
?:pmid
  • 32556327
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.332
?:rankingScore_hIndex
  • 16
?:title
  • Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all